News
CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF ...
NEW YORK, NY—Both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) appear to be acceptable treatment options for patients with primary mitral regurgitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback